Telomerase activation, cellular immortalization and cancer

Annals of Medicine

Volumn 33, Issue 2, 2001, Pages 123-129

  Hahn, W C ^a   Meyerson, M ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Cancer; Cell immortalization; Telomerase; Telomeres

Indexed keywords

CELL DNA; DNA DIRECTED DNA POLYMERASE; RNA; TELOMERASE;

ARTICLE; CARCINOGENESIS; CELL AGING; CELL IMMORTALIZATION; ENZYME ACTIVITY; GENE ACTIVATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TELOMERE; TRANSACTIVATION;

EID: 0035045477     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853890109002067     Document Type: Article

References (99)

1. The stability of broken ends of chromosomes in Zea mays
2. Healing of broken linear dicentric chromosomes in yeast
3. Principle of marginotomy in template synthesis of polynucleotides
4. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of poly-nucleotides and biological significance of the phenomenon
5. Origin of concatemeric T7 DNA
6. Role of telomerase in normal and cancer cells
7. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes
8. Conservation of the human telomere sequence (TTAGGG)n among vertebrates
9. Structure and variability of human chromosome ends
10. An overhanging 3′ terminus is a conserved feature of telomeres
11. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening
12. The terminal DNA structure of mammalian chromosomes
13. Normal human chromosomes have long G-rich telomeric overhangs at one end
14. Mammalian telomeres end in a large duplex loop
15. A human telomeric protein
16. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2
17. Telomeric localization of TRF2, a novel human telobox protein
18. Control of telomere length by the human telomeric protein TRF1
19. TRF2 protects human telomeres from end-to-end fusions
20. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres
21. Tankyrase promotes telomere elongation in human cells
22. Identification of human Rap1: Implications for telomere evolution
23. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
24. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs
25. The RNA component of human telomerase
26. TLC1: Template RNA component of Saccharomyces cerevisiae telomerase
27. Reverse transcriptase motifs in the catalytic subunit of telomerase
28. The catalytic subunit of yeast telomerase
29. Telomerase catalytic subunit homologs from fission yeast and human
30. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
31. Human telomerase contains evolutionarily conserved catalytic and structural subunits
32. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas
33. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
34. Reconstitution of human telomerase activity in vitro
35. Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding
36. Telomerase RNA bound by protein motifs specific to telomerase reverse transcriptase
37. The serial cultivation of human diploid cell strains
38. Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames
39. Defining the molecular mechanisms of human cell immortalization
40. Can ends justify the means?: Telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells
41. Telomeres shorten during ageing of human fibroblasts
42. Telomerase, cell immortality, and cancer
43. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
44. Specific association of human telomerase activity with immortal cells and cancer
45. Telomerase activity in human ovarian carcinoma
46. A survey of telomerase activity in human cancer
47. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues
48. Expression profile of the putative catalytic subunit of the telomerase gene
49. Extension of life-span by introduction of telomerase into normal human cells
50. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
51. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase
52. Human endothelial cell life extension by telomerase expression
53. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics
54. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype
55. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase
56. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
57. Immortalization of human CD8(+) T cell clones by ectopic expression of telomerase reverse transcriptase
58. Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8(+) T lymphocyte immortalization
59. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types
60. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes
61. Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells
62. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization
63. Telomerase activity is sufficient to allow transformed cells to escape from crisis
64. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening
65. Creation of human tumour cells with defined genetic elements
66. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
67. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts
68. Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase
69. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit
70. Telomerase is controlled by protein kinase Calpha in human breast cancer cells
71. Telomerase regulation during entry into the cell cycle in normal human T cells
72. Telomerase is up-regulated in human germinal center B cells in vivo and can be re-expressed in memory B cells activated in vitro
73. Telomeres in the haemopoietic system
74. Telomere lengthening and telomerase activation during human B cell differentiation
75. Regulation of telomerase RNA template expression in human T lymphocyte development and activation
76. Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization
77. Frequent amplification of the telomerase reverse transcriptase gene in human tumors
78. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation
79. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT)
80. Myc activates telomerase
81. Direct activation of TERT transcription by c-MYC
82. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1
83. Identification of Mad as a repressor of the human telomerase (hTERT) gene
84. Estrogen activates telomerase
85. Telomerase activation by the E6 gene product of human papillomavirus type 16
86. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length
87. The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene
88. Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells
89. Inhibition of telomerase limits the growth of human cancer cells
90. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells
91. Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA
92. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death
93. Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells
94. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
95. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans
96. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells
97. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
98. An alternative pathway for yeast telomere maintenance rescues est1-senescence
99. Formation of functional tissue from transplanted adrenocortical cells expressing telomerase reverse transcriptase